Please note: This event will not take place on Saturday 25 April 2020. This page will be updated as soon as we have more details, and we will also contact booked delegates directly with this information. We apologise for any inconvenience this may have caused.
Leading innovators and entrepreneurs will be gathering at the Royal Society of Medicine to take part in the Society’s 20th Medical Innovations Summit.
The Summit provides a biannual platform for the presentation and discussion of inspirational ideas and developments in the field of medicine and healthcare, bringing together clinicians, entrepreneurs, policy-makers and VCs.
For the landmark 20th Medical Innovations Summit, the RSM will host a 4-hour morning conference bringing together the best elements of previous Summits, with presentations from top medical innovators and researchers, as well as a networking ‘Pitch Cafe’ featuring early-stage entrepreneurs from two of the UK’s leading accelerator programmes.
During the first two sessions, there will be talks and discussions from our key speakers. These sessions are designed to showcase some of the world’s top medical ideas and offer the opportunity to hear from leading thinkers in the field to demonstrate and debate the current, and future, state of medical innovation.
Pitch Cafe
During the networking breaks, we are running a ‘Pitch Cafe’ in The Atrium of the RSM. Six entrepreneurs from two accelerator programmes, the InnovationRCA and the MedTech SuperConnector, will be stationed on tables, informally presenting their medical ventures and chatting with delegates.
The Pitch Cafe is a part of an on-going collaboration with these accelerators to connect entrepreneurs with the clinical expertise available across the RSM’s network.
By bringing together both established Medtech companies and researchers with exciting early-stage entrepreneurs, the RSM’s Medical Innovations Summit aims to give delegates the chance to hear from, and engage with, the people who are driving medical innovation forward.
Join in the conversation online using #MedInnov
Follow us on Twitter: @RoySocMed
Co-founder and Chairman, Liva Healthcare UK Ltd
Rune Bech is the co-founder and chairman of the award-winning health tech company Liva Healthcare. Rune Bech was one of Europe’s “dotcom front-runners” in 1998 when he co-founded NetDoctor, a leading European independent health information portal. So far, Rune has co-founded and matured three digital health companies over 22 years, with Liva Healthcare being the latest venture.
Faculty of Engineering, Dyson School of Design Engineering
Dr Nejra van Zalk is a lecturer and researcher in psychology and human factors at the Dyson School of Design Engineering. Within the school, she is head of the Design Psychology Lab, which focuses on understanding psychological mechanisms that govern human behaviour, emotions, and decision-making processes related to designing products, services, and behavioural interventions that benefit mental health.
Her research areas include the development of psychopathology (such as social anxiety and depression) and its effects on online/offline social networks and relationships, human-technology interaction, behavioural stability and change, and emotion mapping.
Co-founder and CEO, Cognetivity Neurosciences Ltd
Dr Habibi simplifies complex challenges and develops compelling and collaborative ways to solve them. In addition to business executive roles, he has experience in research (nano-technology and synthetic biology), product management, and high-tech consultancy (big data and fintech).
Sina has been an active member of Cambridge University Entrepreneurs (CUE) since 2010 and chaired the society in 2013-2014. CUE is the most successful entrepreneurial student society in Europe (funding over 60 start-ups worth over USD300 Million, providing over 500 full-time jobs).
Professor of Physics, University of Bath
Alain Nogaret is a Professor of Physics at the University of Bath, where his research focuses on quantum and nonlinear electronics.
His group has successfully developed nonlinear optimization methods for inferring the parameters of key ion channels from time series analysis of electrophysiological recordings of biological cells.
This approach has paved to way to computational models capable of predicting neuron oscillations and bioelectronic chips that emulate the electrical response of hippocampal and respiratory neurons. As implants, the biochips provide unique therapies for chronic and often fatal diseases such as heart failure the potential of which is beginning to be explored.
Professor Sir Simon Wessely, President, Royal Society of Medicine
Chair:
Hugh Lloyd-Jukes, Chief Executive Officer, Oxehealth
Dr Nejra van Zalk, Faculty of Engineering, Dyson School of Design Engineering, Imperial College London
Rune Bech, Co-founder and Chairman, Liva Healthcare
To be confirmed
Chair:
To be confirmed
Dr Sina Habibi, Co-founder and Chief Executive Officer, Cognetivity
Professor Alain Nogaret, University of Bath Department of Physics
Maria Hahn, Founder and Chief Executive Officer, Nutrix
After session two, there will be a Pitch café running in the Atrium, where entrepreneurs from the InnovationRCA and the MedTech SuperConnector programme will be stationed on tables, informally presenting their medical ventures and devices to delegates.
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
